ME-609
Sponsors
Medivir
Conditions
Herpes Labialis
Phase 2
Phase 3
Efficacy and Safety Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis
CompletedNCT00361881
Start: 2006-07-31End: 2007-12-31Updated: 2008-08-18
Safety Study of ME-609 for Treatment of Herpes Simplex Labialis in Adolescents
CompletedNCT00375570
Start: 2006-10-31End: 2007-09-30Updated: 2008-08-18
Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis in Immunocompromised Patients
CompletedNCT00735761
Start: 2006-12-31End: 2007-09-30Updated: 2008-08-15